Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Health Effects of Soccer Training in Men With Prostate Cancer Receiving Androgen Deprivation Therapy

16 de abril de 2014 actualizado por: Jacob Uth, University of Copenhagen

A Randomized Controlled Clinical Trial on the Effects of Recreational Soccer Training in Men With Prostate Cancer Receiving Androgen Deprivation Therapy: The FC Prostate Study

Androgen Deprivation Therapy (ADT) is standard treatment for locally advanced or advanced Prostate Cancer (PC).

The musculoskeletal toxicity associated with ADT is well established, leading to a decrease in muscle mass, increased fat percentage, weight gain, sexual dysfunction and increased risk of depression, fatigue, diabetes, cardiovascular disease and reduced quality of life.

Numerous studies have shown an association between physical activity, physical capacity and quality of life in cancer patients and recent epidemiological research suggest that regular, moderate-intensity physical activity may have a positive effect on survival in men with prostate cancer.

Within exercise physiology there is new evidence pointing to recreational soccer as a unique form of intermittent exercise that effectively stimulates aerobic and anaerobic energy delivery systems, leading to beneficial musculoskeletal, metabolic and cardiovascular adaptations of importance for health.

It is our overall hypothesis that 12 weeks of recreational soccer training 2-3 times per week will improve the health profile of PC patients receiving ADT treatment.

Descripción general del estudio

Tipo de estudio

Intervencionista

Inscripción (Actual)

57

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Copenhagen, Dinamarca, 2100
        • University of Copenhagen, Centre of Integrated Rehabilitation of Cancer Patients

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años a 75 años (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Masculino

Descripción

Inclusion Criteria:

- Patients with locally advanced or advanced prostate cancer being treated with androgen deprivation therapy (S-testosterone < 1.7) for at least 6 months at the time of inclusion

Exclusion Criteria:

  • WHO performance level above 1,symptomatic cardiovascular disorders, osteoporosis (T-score below -2.5)

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Cuidados de apoyo
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación paralela
  • Enmascaramiento: Ninguno (etiqueta abierta)

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Sin intervención: Grupo de control
Cuidado usual
Comparador activo: Soccer Training
12 weeks of soccer training. (2 times per week for the first 8 weeks and 3 times per week in the last 4 weeks. Training will consist of 15 minutes warm-up and 2 x 15 minutes matches for the first 4 weeks and of 15 minutes warm-up and 3 x 15 minutes matches for the last 8 weeks). After 12 weeks assessments participants in the intervention group will continue bi-weekly supervised training for additional 20 weeks at the end of which tests will be repeated.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Baseline to post intervention (12 weeks) and follow-up (32 weeks) change in Body Composition.
Periodo de tiempo: Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Changes in body composition assessed by Dual-energy X-ray absorptiometry(DXA)scan
Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Bone Mineral Density
Periodo de tiempo: Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Cardiorespiratory fitness (Vo2 peak)
Periodo de tiempo: Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Change in maximal oxygen consumption (Vo2 peak) assessed directly during an incremental test on a cycle ergometer from baseline to post-intervention (12 weeks) and follow-up (32 weeks).
Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Patient reported outcomes
Periodo de tiempo: Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Changes in Psychological distress (Hospital Anxiety and Depression Scale, HADS), Quality of Life (EORTC QLQ C-30), general well-being (SF-36), disease specific symptoms and side-effects (EORTC PR-25)from baseline to post-intervention (12 weeks) and follow-up (32 weeks)
Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Heart function
Periodo de tiempo: Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Changes in Heart function measured by Echocardiography from baseline to post-intervention (12 weeks) and follow-up (32 weeks)
Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Glucose tolerance
Periodo de tiempo: Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Oral Glucose Tolerance Test
Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Postural Balance
Periodo de tiempo: Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Assessed standing on a force platform with feet in bilateral, unilateral and tandem position. Additionally assessed with a modified Flamingo balance test.
Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Physical function
Periodo de tiempo: Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Physical function will be assessed with sit to stand test (30s), stair climbing test and Counter Movement Jump (jump height)
Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Hip to waist ratio
Periodo de tiempo: Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Hip and waist circumference will be measured and the hip to waist ratio will be calculated
Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Muscle Strength
Periodo de tiempo: Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Muscle strength will be assessed with the 1Repetition Maximum test for knee extensors
Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Blood markers
Periodo de tiempo: Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)
Markers of inflammation and bone metabolism will be obtained after overnight fasting
Change from baseline to post intervention (12 weeks) and follow-up (32 weeks)

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Mikael Rørth, Professor, University of Copenhagen

Publicaciones y enlaces útiles

La persona responsable de ingresar información sobre el estudio proporciona voluntariamente estas publicaciones. Estos pueden ser sobre cualquier cosa relacionada con el estudio.

Publicaciones Generales

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio

1 de marzo de 2012

Finalización primaria (Actual)

1 de diciembre de 2013

Finalización del estudio (Actual)

1 de diciembre de 2013

Fechas de registro del estudio

Enviado por primera vez

17 de octubre de 2012

Primero enviado que cumplió con los criterios de control de calidad

18 de octubre de 2012

Publicado por primera vez (Estimar)

22 de octubre de 2012

Actualizaciones de registros de estudio

Última actualización publicada (Estimar)

21 de abril de 2014

Última actualización enviada que cumplió con los criterios de control de calidad

16 de abril de 2014

Última verificación

1 de abril de 2014

Más información

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Ensayos clínicos sobre Soccer training

Suscribir